CIM LLC’s Abiomed Inc ABMD Stock Holding History

CIM LLC’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,475	Closed	-$663K	–	125
2018 Q3	$663K	Buy	1,475 +21	+1%	+$8.28K	0.24%	55
2018 Q2	$595K	Buy	+1,454	New	+$527K	0.21%	52

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIM LLC's ABMD Position: Q4 2018 in Review

CIM LLC sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 1,475 shares — an estimated $663K sold.

CIM LLC first reported a position in ABMD in Q2 2018 and held it in 2 quarters. The position peaked at $663K in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

CIM LLC reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
CIM LLC sold 1,475 Abiomed Inc shares in Q4 2018, an estimated $663K.
CIM LLC first reported a position in Abiomed Inc in Q2 2018 and held it in 2 quarters.
CIM LLC's Abiomed Inc position peaked at $663K in Q3 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on CIM LLC's 13F filing for Q4 2018, filed 29 Jan 2019.